| Catalog No. |
TD-AB941014 |
| Applications |
ELISA |
| Host species |
Rabbit |
| Isotype |
IgG |
| Clonality |
Polyclonal |
| Immunogen |
Ranibizumab |
| Target |
Rabbit polyclonal to Lucentis. |
| Specificity |
The product is specific for Ranibizumab. This antibody serves as an excellent positive control for Ranibizumab immunogenicity (ADA) assays. |
| Purification |
Purified by antigen affinity column. |
| Accession |
CAS: 347396-82-1 |
| Form |
Liquid |
| Storage buffer |
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. |
| Stability and Storage |
The product can be stored for 2 - 3 weeks at 2 to 8°C or for up to 12 months at -20°C. Avoid repeated freezing and thawing cycles. |
| Background |
Ranibizumab with trade name Lucentis, is an FDA-approved drug for the treatment of patients with neovascular (Wet) age-related macular degeneration (AMD) and macular edema following retinal vein occlusion (RVO). It is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment. Ranibizumab binds to vascular endothelial growth factor A (VEGF-A) and blocks its activity. Antibodysystem Anti-Ranibizumab Antibody, pAb, Rabbit is produced from sera of a rabbit immunized with Ranibizumab. |
| Note |
Antibodysystem can customize this product per customer's request including product size, buffer components, etc. For research use only. |
抗体
试剂盒
多肽
探针
蛋白
组织芯片
定制服务咨询